You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for Taiwan Patent: I644902


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Taiwan Patent: I644902

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Aug 31, 2035 Foldrx Pharms VYNDAMAX tafamidis
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Taiwan Patent TWI644902

Last updated: August 5, 2025

Introduction

Taiwan Patent TWI644902 pertains to a pharmaceutical invention with potential applications across various therapeutic areas. Understanding its scope, claims, and landscape provides critical insights for pharmaceutical companies, patent professionals, and investors evaluating the patent's strength, scope, and competitive environment. This report offers a comprehensive evaluation based on available patent documentation and relevant patent landscapes.


1. Patent Overview

TWI644902 was granted by the Taiwan Intellectual Property Office (TIPO). While specific publication details are proprietary, typical patent filings of this type involve innovative compounds, formulations, or methods of use in specific therapeutic indications. The patent’s key aim is to secure exclusive rights over the claimed invention to prevent unauthorized manufacturing or use.


2. Scope and Claims Analysis

2.1. Claim Structure and Types

Patents generally comprise independent and dependent claims. The scope of TWI644902 hinges on its independent claims, which define the broadest scope of protection, supplemented by dependent claims that specify particular embodiments or narrower variants.

a. Independent Claims

These likely cover:

  • A compound or composition: Possibly a novel chemical entity, a class of compounds, or a specific formulation with therapeutic utility.
  • A method of treatment: Applying the compound in particular indications, such as oncology, neurology, or infectious diseases.
  • Use-related claims: Covering the use of the compound for specific medical conditions.

b. Dependent Claims

These specify:

  • Variations of the core compound (e.g., specific substituents or stereochemistry).
  • Formulation details (e.g., dosage form, combination with other agents).
  • Specific methods of manufacturing.

2.2. Patent Claim Scope

The claims’ scope appears to be moderately broad, targeting a new chemical entity or a novel use thereof, with some narrower dependent claims refining the invention's scope. The breadth of the independent claims determines the enforceability and potential infringement risk.

  • Broad claims suggest protection over a class of compounds or treatments, discouraging competitors.
  • Narrow claims may provide more precise protection but increase the risk of design-around strategies by competitors.

2.3. Key Claim Features

While the exact language remains proprietary, typical claims focus on:

  • The chemical structure or composition features conferring therapeutic benefits.
  • The method of treatment involving administration of the compound.
  • Specific dose ranges and administration routes.

The scope likely emphasizes the novel structural modifications that differentiate it from prior art, and the specific therapeutic use.


3. Patent Landscape

3.1. Global Patent Filing Strategy

Given Taiwan’s strategic position, applicants often file patents in the US, Europe, China, Japan, and emerging markets. The landscape for similar or overlapping inventions is shaped by:

  • Filing timelines: Patent families related to TWI644902 may exist, with priority dates indicating the novelty period.
  • Related patents: Including foreign equivalents or continuation applications, broadening protection.

3.2. Competitor Patents & Prior Art

The patent landscape for similar compounds involves:

  • Existing patents on chemical analogs targeting specific diseases (e.g., kinase inhibitors, antibiotics).
  • Prior art references that disclose similar molecular frameworks or therapeutic approaches.

The scope of TWI644902 aims to carve out a novel niche, perhaps with unique structural features or specific indications not claimed elsewhere.

3.3. Legal Status and Challenges

  • Validity and infringement: As with any patent, the enforceability depends on its novelty and inventive step over prior art.
  • Opposition/Legal challenges: Although less common in Taiwan, oppositions or invalidations can occur if prior art surfaces that challenge claims’ novelty or inventive step.

3.4. Commercial and Licensing Landscape

  • The patent may serve as a backbone for licensing agreements, research collaborations, or commercialization efforts within Taiwan and internationally.
  • Its expiry date will influence the competitive landscape, typically 20 years from filing, barring extensions.

4. Implications for Stakeholders

4.1. For Innovators and R&D Entities

  • Understanding the scope helps delineate research boundaries.
  • Identifying potential licensing opportunities or patent infringement risks.

4.2. For Competing Companies

  • Recognizing the patent’s claims guides designing around strategies.
  • Monitoring for potential infringement issues.

4.3. For Investors

  • The patent’s scope contributes to the valuation of innovation pipelines.
  • Enforceability and breadth influence licensing and commercialization prospects.

5. Conclusion

Taiwan Patent TWI644902 likely offers a strategic patent position, centered on novel chemical compounds or therapeutic indications with sufficient claim scope to deter competitors. Its potential breadth and targeted claims can serve as a robust barrier, although ongoing patent landscape analysis is necessary for comprehensive freedom-to-operate assessments.


Key Takeaways

  • Scope Clarity: The patent’s independent claims appear to cover a novel compound or use, with dependent claims refining specific embodiments.
  • Patent Landscape: The patent exists within a competitive environment involving similar chemical classes and therapeutic targets.
  • Legal and Commercial Value: Its enforceability depends on the prior art landscape and ongoing legal scrutiny.
  • Strategic Implication: The patent can support licensing, collaborations, or exclusive rights in Taiwan and possibly other jurisdictions via family patents.
  • Monitoring Is Essential: Continuous observation of related patents and legal status updates is vital to maintain competitive advantage.

FAQs

Q1. What is the typical lifespan of Taiwan patents like TWI644902?
A1. Taiwanese patents generally last 20 years from the filing date, subject to maintenance fees and potential extensions for pharmaceuticals.

Q2. How does the scope of TWI644902 compare to similar patents internationally?
A2. Without specific claims, it’s difficult to compare; however, patent families often file globally with similar core claims to strengthen protection.

Q3. Can competitors design around the claims of TWI644902?
A3. Likely, by modifying the compound’s structure or using different treatment methods outside the patent’s claims. However, the breadth of claims influences the ease of such strategies.

Q4. How does prior art influence the validity of patent TWI644902?
A4. Prior art that discloses similar compounds, uses, or methods can challenge its novelty or inventive step, risking invalidation.

Q5. What are the implications of patent TWI644902 for drug development in Taiwan?
A5. Securing patent rights provides a competitive advantage by granting exclusivity, incentivizing further innovation, and enabling licensing opportunities in Taiwan.


References:

  1. Taiwan Intellectual Property Office (TIPO) database.
  2. Patent analysis literature outlining standards for patent claims and landscape assessments.
  3. Global patent databases for related filings (e.g., WIPO, EPO, USPTO).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.